Cochrane Abstracts
Amantadine for dyskinesia in Parkinson's disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Amantadine for Dyskinesia in Parkinson's Disease." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434822/all/Amantadine_for_dyskinesia_in_Parkinson's_disease. Accessed 30 September 2023.
Amantadine for dyskinesia in Parkinson's disease. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434822/all/Amantadine_for_dyskinesia_in_Parkinson's_disease. Accessed September 30, 2023.
Amantadine for dyskinesia in Parkinson's disease. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/434822/all/Amantadine_for_dyskinesia_in_Parkinson's_disease
Amantadine for Dyskinesia in Parkinson's Disease [Internet]. In: Cochrane Abstracts. [cited 2023 September 30]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434822/all/Amantadine_for_dyskinesia_in_Parkinson's_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Amantadine for dyskinesia in Parkinson's disease
ID - 434822
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434822/all/Amantadine_for_dyskinesia_in_Parkinson's_disease
DB - Evidence Central
DP - Unbound Medicine
ER -
